XK and influenza: Although HA mutations that alter viral receptor affinity/specificity can contribute to NA inhibitor resistance in vitro by allowing efficient virus release from infected cells without the need for significant NA activity [9], [11]–[18], the importance of HA mutations in the clinical management of influenza in humans remains uncertain [11], [19]–[23].